Advertisement
Screener

Omada Health, Inc. (OMDA) Investment Income, Interest

2.5 / 5 stars · 4/8 Roast Me

Omada Health, Inc. Investment Income, Interest

Omada Health, Inc. (OMDA) reported Investment Income, Interest of $1.76 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.

Financial Statements › Income Statement › Other Income

us-gaap:InvestmentIncomeInterest · last filed 2026-08-07

  • Omada Health, Inc. investment income, interest for the quarter ending 2026-06-30 was $1.76M, a 103.82% increase year-over-year.
  • Omada Health, Inc. investment income, interest for the quarter ending 2026-03-31 was $1.83M, a 237.45% increase year-over-year.
  • Omada Health, Inc. investment income, interest for the quarter ending 2025-12-31 was $1.89M, a 986.78% increase year-over-year.
  • Omada Health, Inc. investment income, interest for the quarter ending 2025-09-30 was $2.01M, a 11717.65% increase year-over-year.
  • Omada Health, Inc. investment income, interest for fiscal 2025 was $5.30M, a 559.01% increase from fiscal 2024.
  • Omada Health, Inc. investment income, interest for fiscal 2024 was $805.00K, a 86.06% decline from fiscal 2023.
  • Omada Health, Inc. investment income, interest for fiscal 2023 was $5.78M.
Period endInvestment Income, Interest 3 monthInvestment Income, Interest 6 monthInvestment Income, Interest 9 monthInvestment Income, Interest 12 month
2026-06-30$1.76M
10-Q · filed 2026-08-07
$3.59M
10-Q · filed 2026-08-07
$5.48M
derived: sum of 3 quarters · filed 2026-08-07
$7.49M
derived: sum of 4 quarters · filed 2026-08-07
2026-03-31$1.83M
10-Q · filed 2026-05-08
$3.72M
derived: sum of 2 quarters · filed 2026-05-08
$5.73M
derived: sum of 3 quarters · filed 2026-05-08
$6.59M
derived: sum of 4 quarters · filed 2026-08-07
2025-12-31$1.89M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06
$3.90M
derived: sum of 2 quarters · filed 2026-03-06
$4.76M
derived: sum of 3 quarters · filed 2026-08-07
$5.30M
10-K · filed 2026-03-06
2025-09-30$2.01M
10-Q · filed 2025-11-07
$2.87M
derived: sum of 2 quarters · filed 2026-08-07
$3.41M
10-Q · filed 2025-11-07
$3.59M
derived: sum of 4 quarters · filed 2026-08-07
2025-06-30$863.00K
10-Q · filed 2026-08-07
$1.41M
10-Q · filed 2026-08-07
$1.58M
derived: sum of 3 quarters · filed 2026-08-07
$1.60M
derived: sum of 4 quarters · filed 2026-08-07
2025-03-31$542.00K
10-Q · filed 2026-05-08
$716.00K
derived: sum of 2 quarters · filed 2026-05-08
$733.00K
derived: sum of 3 quarters · filed 2026-05-08
$818.00K
derived: sum of 4 quarters · filed 2026-05-08
2024-12-31$174.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-06
$191.00K
derived: sum of 2 quarters · filed 2026-03-06
$276.00K
derived: sum of 3 quarters · filed 2026-03-06
$805.00K
10-K · filed 2026-03-06
2024-09-30$17.00K
10-Q · filed 2025-11-07
$102.00K
derived: sum of 2 quarters · filed 2025-11-07
$631.00K
10-Q · filed 2025-11-07
2024-06-30$85.00K
10-Q · filed 2025-08-08
$614.00K
10-Q · filed 2025-08-08
2023-12-31$5.78M
10-K · filed 2026-03-06

Similar stocks

Stock NameCountryMarket CapPE Ratio
InnovAge Holding Corp. (INNV)United States$1.206B-635.60
U S PHYSICAL THERAPY INC /NV (USPH)United States$1.251B32.48
Pennant Group, Inc. (PNTG)United States$1.386B39.84
Strata Critical Medical, Inc. (SRTA)United States$0.467B11.33
DocGo Inc. (DCGO)United States$0.034B-0.25
VSEE HEALTH, INC. (VSEE)United States$0.003B
Agape ATP Corp (ATPC)$0.002B
Privia Health Group, Inc. (PRVA)United States$2.477B115.52
GeneDx Holdings Corp. (WGS)United States$2.638B-19.23
LifeStance Health Group, Inc. (LFST)United States$4.510B80.86